Tolerability of Once-Weekly Alendronate in Patients With Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Study

This publication has 18 references indexed in Scilit:

• Comparative Safety of Bone Remodeling Agents with a Focus on Osteoporosis Therapies
  The Journal of Clinical Pharmacology, 2001
• Treatment of Osteoporosis with Bisphosphonates
  Rheumatic Disease Clinics of North America, 2001
• Fracture Risk Reduction with Alendronate in Women with Osteoporosis: The Fracture Intervention Trial
  Journal of Clinical Endocrinology & Metabolism, 2000
• Weekly administration of alendronate: Rationale and plan for clinical assessment
  Clinical Therapeutics, 2000
• Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study
  Osteoporosis International, 1999
• Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral FracturesResults From the Fracture Intervention Trial
  JAMA, 1998
• Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis
  New England Journal of Medicine, 1998
• Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
  The Lancet, 1996
• Adverse Effects of Bisphosphonates
  Drug Safety, 1996
• Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
  New England Journal of Medicine, 1995